GL1X · GenesisL1 explorer

MolNFT v1 · #187741 · protein

Crystal structure of an acidic pH-selective ipilimumab variant IPI.105 in complex with ctla-4

7SU0 · Cytotoxic T-lymphocyte protein 4: “Crystal structure of an acidic pH-selective ipilimumab variant IPI.105 in complex with ctla-4”. X-ray diffraction, 1 ligand (NAG), 12 pockets (best druggability 0.76). MolNFT v1 #187741 on…

PDB
7SU0
Type
protein
Length
1,081 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytotoxic T-lymphocyte protein 4; Fab heavy chain; Fab light chain
UniProt
P16410
Ligands
NAG
Pockets
12 · best druggability 0.76

Structure

x-ray diffraction · 6 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CCytotoxic T-lymphocyte protein 4protein1173% helix, 56% strandP16410
HFab heavy chainprotein2128% helix, 52% strand—
LFab light chainprotein2145% helix, 52% strand—
DCytotoxic T-lymphocyte protein 4protein1163% helix, 57% strandP16410
IFab heavy chainprotein2107% helix, 53% strand—
MFab light chainprotein2126% helix, 50% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains C, D
  • FLC · Citrate anion · additive · chains D, I, M
  • PEG · Di(hydroxyethyl)ether · additive · chains I, M

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17900.760.8199empty
24680.600.7537empty
32700.550.7728empty
43650.550.7444PEG
51780.540.7928FLC

Interfaces

10 interfaces between chains.

  • H–L · 1600 Ų buried · 6 hydrogen bonds · protein-protein
  • I–M · 1590 Ų buried · 8 hydrogen bonds · protein-protein
  • D–I · 630 Ų buried · 7 hydrogen bonds · protein-protein
  • C–H · 590 Ų buried · 6 hydrogen bonds · protein-protein
  • D–M · 400 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide, 3 glycan, 2 modified (disulfide, N-glycosylation, cyclization).

Compared structures

  • 7SU0 · Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with… · the same entry in another collection · chain M against M, TM-score 1.00
  • P16410 · AlphaFold monomer V2.0 prediction for cytotoxic T-lymphocyte protein 4 (P16410) · a predicted model of the same protein · chain D against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.